Ocrevus Zunovo for Multiple Sclerosis
Ocrevus Zunovo for MS: Mixed Methods
Recruiting
Observational Study
Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Northwestern University · Other
Who this trial is looking for
This trial is looking for people with multiple sclerosis who are interested in starting or restarting a specific treatment called Ocrevus Zunovo. Participants will share their experiences through surveys and interviews over a year.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years old or older
- I live in the USA
- I have been seen at Northwestern Medicine
- I have a confirmed diagnosis of MS
- I want to start or restart a treatment for MS
- I am willing to participate in a 12-month follow-up study
You may not be able to join if
- I have an unclear diagnosis of MS
- I am currently in prison
- I cannot give informed consent
- I am currently participating in another trial for MS
- I have a serious or terminal illness
- I cannot speak a language that consent forms are available in
- I am currently pregnant or breastfeeding
- I have had an allergic reaction to Ocrelizumab or similar treatments
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Ocrevus Zunovo implementation, feasibility, acceptability, patient satisfaction, treatment persistence, and impact on MS disease outcomes will be analyzed in this mixed methods study. This study will incorporate clinical data and questionnaire results from MS patients who take Ocrevus Zunovo as well as qualitative interviews with MS patients, family members, and other individuals involved in Ocrev…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age of 18 years or older
* Resident of the USA
* Seen at Northwestern Medicine
* Meets diagnostic criteria (2024) for MS, either RMS or PPMS
* Diagnosis of MS (G35) on file by a neurologist
* Wants to start or restart a DMT for MS
* Willing to be in a 12-month follow up study
…
Contacts